Phage microarray profiling of the humoral response to disease
US10006023B2 · kind B2 · utility
0Cited by
63References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2016 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Oct 17, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.